Additionally, the pre-treatment frequency of CD56++CD16dim NK cells was significantly higher, and that of CD16++CD56dim NK cells was significantly lower in cases that developed early HCC after IFN-free DAAs (Fig 2B). This evidence concerns the gene IFNA1 and hepatocellular carcinoma.